Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-022232
Filing Date
2017-04-07
Accepted
2017-04-07 16:20:10
Documents
5
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-2115_3defa14a.htm DEFA14A 32441
2 GRAPHIC g21153bci001.jpg GRAPHIC 75795
3 GRAPHIC g21153bci002.jpg GRAPHIC 115983
4 GRAPHIC g21153bci003.jpg GRAPHIC 46286
5 GRAPHIC g21153bci004.jpg GRAPHIC 25389
  Complete submission text file 0001104659-17-022232.txt   396706
Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30739 | Film No.: 17749764
SIC: 2834 Pharmaceutical Preparations